Playback speed
10 seconds
Non-Invasive Assessment of NASH/NAFLD: Can Elastography/Serum-Based Fibrosis Biomarkers Help Stratify the Risk of Advanced Fibrosis? What Is the Main Prognostic Determinant of NAFLD Outcomes?
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Rohit Loomba
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Rohit Loomba
224 views
February 15, 2021
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
Didactic Presentations
30th Annual San Diego Heart Failure Symposium: Advances in the Recog…
Fri, Jul 19, 2024